Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer

CompletedOBSERVATIONAL

Enrollment

223

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2021

Conditions

Metastatic Breast CancerCirculating Tumor DNAGene Abnormality

Interventions

DRUG

Control group

Physician chosen treatment

DRUG

Case group

Druggable ctDNA alterations-guided therapy

All Listed Sponsors

lead

Hunan Cancer Hospital

OTHER

NCT05427617 - Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer | Biotech Hunter | Biotech Hunter